| MR |
Wuhu (Anhui Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
26. Juli 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| R2R Specialist - Inventory |
Selangor |
Malaysia |
Finance |
CTS |
Audit und Finanzen |
28. Juli 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| 区域市场组经理 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Marketing |
28. Juli 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
28. Juli 2024 |
| Global Procurement Category Manager, Chemicals |
Prague |
Tschechische Republik |
Operations |
CTS |
Beschaffung |
29. Juli 2024 |
| Clinical Development Medical Manager |
Shanghai (Shanghai) |
China |
Development |
Innovative Medicines |
Research & Development |
29. Juli 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
30. Juli 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
30. Juli 2024 |
| Third Party Risk Management Specialist |
Prague |
Tschechische Republik |
Operations |
CTS |
Beschaffung |
30. Juli 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
30. Juli 2024 |
| County Executive |
Maoming (Guangdong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
30. Juli 2024 |
| Product Specialist |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
30. Juli 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
30. Juli 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
30. Juli 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
30. Juli 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
30. Juli 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
30. Juli 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
30. Juli 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
30. Juli 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
30. Juli 2024 |
| Technical System Lead (Qualification) |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Technical Operations |
31. Juli 2024 |
| Pricing Manager |
New South Wales (NSW) |
Australien |
International |
Innovative Medicines |
Market Access |
31. Juli 2024 |
| MS&T Expansion Lead RLT Sasayama |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Technical Operations |
31. Juli 2024 |
| Head Engineering (m/f/d) |
Puurs |
Belgien |
Operations |
Innovative Medicines |
Technical Operations |
01. August 2024 |
| Sales Value Associate CDMX - Privado |
INSURGENTES |
Mexiko |
International |
Innovative Medicines |
Der Umsatz |
01. August 2024 |
| Elektroniker (m/w/d) der Fachrichtung Betriebstechnik im Bereich Facility Management |
Wehr (Novartis Pharma Produktions GmbH) |
Deutschland |
Operations |
Innovative Medicines |
Technical Operations |
02. August 2024 |
| Mechaniker (m/w/d) im Bereich Facility Management |
Wehr (Novartis Pharma Produktions GmbH) |
Deutschland |
Operations |
Innovative Medicines |
Technical Operations |
02. August 2024 |
| Engineer (Multidiscipline) (m/w/d) im Bereich Facility Management |
Wehr (Novartis Pharma Produktions GmbH) |
Deutschland |
Operations |
Innovative Medicines |
Technical Operations |
02. August 2024 |
| Facility Expert (m/w/d) im Bereich Facility Management (80%) |
Wehr (Novartis Pharma Produktions GmbH) |
Deutschland |
Operations |
Innovative Medicines |
Technical Operations |
02. August 2024 |